The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
about
Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervixPrimary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervixImage-guided brachytherapy in cervical cancer: past, present and future.A proposed protocol on HDR cylinder treatments: proof of avoidance of re-planning of CT based fractionated treatment, using a critical, statistical and graphical analysis of clinical dataLocalizing intracavitary brachytherapy applicators from cone-beam CT x-ray projections via a novel iterative forward projection matching algorithmImaging across the life span: innovations in imaging and therapy for gynecologic cancer.An integrated approach to segmentation and nonrigid registration for application in image-guided pelvic radiotherapy.The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128.A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer.Clear cell adenocarcinoma of the uterine cervix in a 24-year-old woman. Case report and review of the literature.Comparison of carboplatin- and cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risksA unified framework for joint segmentation, nonrigid registration and tumor detection: application to MR-guided radiotherapy.Simultaneous nonrigid registration, segmentation, and tumor detection in MRI guided cervical cancer radiation therapy.The use of magnetic resonance imaging for image-guided brachytherapy.Current principles for radiotherapy in cervical cancer.The role of imaging in the management of non-metastatic cervical cancer.In vivo dosimetry in brachytherapy.Patterns of care study of brachytherapy in New South Wales: cervical cancer treatment quality depends on caseload.Positional variation of applicators during low dose rate intracavitary brachytherapy for cervical cancer: a prospective study.Biological equivalence between LDR and PDR in cervical cancer: multifactor analysis using the linear-quadratic model.Impact of point A asymmetry on local control and survival for low dose-rate (LDR) brachytherapy in cervical cancer.Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma.Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer.A retrospective study of bladder morbidity in patients receiving intracavitary brachytherapy as all or part of their treatment for cervix cancer.Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: A retrospective comparison with chemoirradiation.Impact of the vaginal applicator and dummy pellets on the dosimetry parameters of Cs‐137 brachytherapy source.
P2860
Q24201754-AA38D8BA-6C61-4E7A-81D9-CFC11B84E5B1Q24241058-AF1D977E-C37B-4228-AF73-23DAE4749D75Q30278740-D6E870D6-ECEF-4934-B3E3-E38E15DA1715Q34560720-30F1C983-6413-4C01-A987-3BBE319DDEC4Q34608331-3E34C9C1-927D-4652-87ED-D6CAC23CF567Q35057017-A71FE9C2-311A-42FB-B07B-83E9A74EEE4CQ35188787-67DA9A1B-5A51-4318-864C-135C4A826ED0Q35635085-333FA652-87FC-4DCA-A510-201B3C4BD850Q35649036-4AE759C9-F9F1-46F3-B30F-0B3B3D42684CQ36105733-41BC859A-E527-4D8F-8D2F-7FAB5B174509Q37038491-323EAAB5-4525-46B0-856B-86180060518AQ37467670-720BBDF2-7CAA-4424-A2E6-09CAB003D659Q37467687-C233715D-F41C-465D-BF29-E764F974F0CFQ37762297-4E415B9B-00C7-4979-9BBC-DC18C648EFACQ37986687-8C8EF42A-22C1-4A21-8DF6-3C326CEA9E19Q38005319-4672E1E6-1902-48DB-818A-8BFBC0BF7CD3Q38119001-E17A5F43-6FD6-44DF-9621-D29513782082Q39029959-6C6B160F-A8AE-4A61-9E8D-5C5ED8E71957Q39842680-232F3B9E-914E-4BF1-B188-AFBE71C00E78Q42912231-A0AC1A25-BAD9-4518-8AB3-15C3A6ACD633Q42912675-9955035E-65EF-4465-A8BD-9E0574312D01Q47887145-FD5F2774-5ABF-4242-822C-089B7878C47AQ48676746-C247BA4D-9B29-4E89-B40F-4D65A2C31B07Q53634720-BF25DF0F-7175-4695-910B-4493B5C88798Q55428407-C3745C0F-962B-4B7A-9869-7BC99A802C54Q55657079-3EB64766-DAD1-480E-A56F-782DF85C99D1
P2860
The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@ast
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@en
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@nl
type
label
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@ast
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@en
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@nl
prefLabel
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@ast
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@en
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@nl
P2093
P1476
The American Brachytherapy Soc ...... y for carcinoma of the cervix.
@en
P2093
Alvaro Martinez
American Brachytherapy Society
Beth Erickson
Bruce Thomadsen
Clifford Chao
Jeffery Fowler
Nilendu Gupta
P356
10.1016/S0360-3016(01)01755-2
P407
P577
2002-01-01T00:00:00Z